VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“Zecotek” or the “Company”) (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that its new subsidiary, Zecotek Imaging China Ltd., has retained the law firm Lexinter Law Group, Shanghai, to safeguard the new manufacturing facility that will produce Zecotek’s patented LFS scintillation crystals in China. With ten offices around the world including Hong Kong and Shanghai, the Lexinter Law Group are experts at protecting intellectual property in any jurisdiction.
“We have retained the Lexinter Law Group to ensure the manufacturing facility for our LFS scintillation crystals in China is secure, protected and is not open to compromise,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “We are very encouraged by the recent comments made by Chinese President Xi Jinping regarding the Chinese economy and enforcement of intellectual property of foreign firms. This reinforces the protection of our patent portfolio surrounding our LFS crystal technology and provides greater confidence to Tier-1 Chinese and international medical device OEM customers operating in and out of China. Most importantly, strong IP regulation together with the best scintillation crystal of its kind, provide for greater sales opportunities for Zecotek. It will facilitate the export of medical scanners by Chinese OEMs which must meet strict international IP requirements. We will protect the integrity of our IP at all times."
Lexinter Law Group is the law firm the world's business leaders from a wide variety of multinational corporations and medium sized enterprises to start-ups, turn to when they want enduring results. The firm has offices in North America, Europe and Asia and is known for protecting intellectual property rights around the world. With a mission to think creatively and proactively in formulating the most effective and efficient solutions to legal needs, Lexinter protects intellectual property rights to create an environment where creativity can flourish and hard work can be rewarded.
Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Optronics Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances with Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Shanghai EBO Optoelectronics Technology Co. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com and follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
T: (604) 783-8291
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com